Skip to main content
. 2010 Dec 14;5(12):e14334. doi: 10.1371/journal.pone.0014334

Figure 6. The immunoreactivity for MEK1 and cyclin E1 in senile hemangioma.

Figure 6

Increased expression of MEK1 (a) or cyclin E1 (b) in ECs of senile hemangioma. Sections of normal skin or vascular anomalies were stained with antibodies against MEK1 or cyclin E1 (green) and CD34 (red). SH; senile hemangioma, VM; vascular malformation.